188 related articles for article (PubMed ID: 29067565)
1. Simple, mild, one-step labelling of proteins with gallium-68 using a tris(hydroxypyridinone) bifunctional chelator: a
Nawaz S; Mullen GED; Sunassee K; Bordoloi J; Blower PJ; Ballinger JR
EJNMMI Res; 2017 Oct; 7(1):86. PubMed ID: 29067565
[TBL] [Abstract][Full Text] [Related]
2.
Young JD; Abbate V; Imberti C; Meszaros LK; Ma MT; Terry SYA; Hider RC; Mullen GE; Blower PJ
J Nucl Med; 2017 Aug; 58(8):1270-1277. PubMed ID: 28408532
[TBL] [Abstract][Full Text] [Related]
3. Rapid kit-based (68)Ga-labelling and PET imaging with THP-Tyr(3)-octreotate: a preliminary comparison with DOTA-Tyr(3)-octreotate.
Ma MT; Cullinane C; Waldeck K; Roselt P; Hicks RJ; Blower PJ
EJNMMI Res; 2015 Dec; 5(1):52. PubMed ID: 26452495
[TBL] [Abstract][Full Text] [Related]
4. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
5. A 99mTc-labelled scFv antibody fragment that binds to prostate-specific membrane antigen.
Nawaz S; Mullen GED; Blower PJ; Ballinger JR
Nucl Med Commun; 2017 Aug; 38(8):666-671. PubMed ID: 28598898
[TBL] [Abstract][Full Text] [Related]
6. Design and preclinical evaluation of a 99mTc-labelled diabody of mAb J591 for SPECT imaging of prostate-specific membrane antigen (PSMA).
Kampmeier F; Williams JD; Maher J; Mullen GE; Blower PJ
EJNMMI Res; 2014 Mar; 4(1):13. PubMed ID: 24602403
[TBL] [Abstract][Full Text] [Related]
7. PSA-stratified detection rates for [
Derlin T; Schmuck S; Juhl C; Zörgiebel J; Schneefeld SM; Walte ACA; Hueper K; von Klot CA; Henkenberens C; Christiansen H; Thackeray JT; Ross TL; Bengel FM
Eur J Nucl Med Mol Imaging; 2018 Jun; 45(6):913-922. PubMed ID: 29308527
[TBL] [Abstract][Full Text] [Related]
8. Simple new method for labelling of PSMA-11 with
Urbanová K; Seifert D; Vinšová H; Vlk M; Lebeda O
Appl Radiat Isot; 2021 Jun; 172():109692. PubMed ID: 33770721
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo evaluation of the bifunctional chelator NODIA-Me in combination with a prostate-specific membrane antigen targeting vector.
Läppchen T; Kiefer Y; Holland JP; Bartholomä MD
Nucl Med Biol; 2018 May; 60():45-54. PubMed ID: 29571066
[TBL] [Abstract][Full Text] [Related]
10. Radiochemistry and In Vivo Imaging of [
Saini S; Mullen GED; Blower PJ; Lapi SE
Mol Pharm; 2024 Feb; 21(2):822-830. PubMed ID: 38173242
[TBL] [Abstract][Full Text] [Related]
11. NHS-Functionalized THP Derivative for Efficient Synthesis of Kit-Based Precursors for
Floresta G; Keeling GP; Memdouh S; Meszaros LK; de Rosales RTM; Abbate V
Biomedicines; 2021 Apr; 9(4):. PubMed ID: 33915871
[TBL] [Abstract][Full Text] [Related]
12. Comparison of macrocyclic and acyclic chelators for gallium-68 radiolabelling.
Tsionou MI; Knapp CE; Foley CA; Munteanu CR; Cakebread A; Imberti C; Eykyn TR; Young JD; Paterson BM; Blower PJ; Ma MT
RSC Adv; 2017 Oct; 7(78):49586-49599. PubMed ID: 29308192
[TBL] [Abstract][Full Text] [Related]
13. Manipulating the In Vivo Behaviour of
Imberti C; Adumeau P; Blower JE; Al Salemee F; Baguña Torres J; Lewis JS; Zeglis BM; Terry SYA; Blower PJ
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32098299
[TBL] [Abstract][Full Text] [Related]
14. A Novel ¹¹¹In-Labeled Anti-Prostate-Specific Membrane Antigen Nanobody for Targeted SPECT/CT Imaging of Prostate Cancer.
Chatalic KL; Veldhoven-Zweistra J; Bolkestein M; Hoeben S; Koning GA; Boerman OC; de Jong M; van Weerden WM
J Nucl Med; 2015 Jul; 56(7):1094-9. PubMed ID: 25977460
[TBL] [Abstract][Full Text] [Related]
15. Clinical Translation and First In-Human Use of [
Eppard E; de la Fuente A; Benešová M; Khawar A; Bundschuh RA; Gärtner FC; Kreppel B; Kopka K; Essler M; Rösch F
Theranostics; 2017; 7(18):4359-4369. PubMed ID: 29158832
[TBL] [Abstract][Full Text] [Related]
16. Assessment of PSMA targeting ligands bearing novel chelates with application to theranostics: Stability and complexation kinetics of
Kelly JM; Amor-Coarasa A; Nikolopoulou A; Kim D; Williams C; Vallabhajosula S; Babich JW
Nucl Med Biol; 2017 Dec; 55():38-46. PubMed ID: 29055836
[TBL] [Abstract][Full Text] [Related]
17. Tuning the properties of tris(hydroxypyridinone) ligands: efficient
Imberti C; Chen YL; Foley CA; Ma MT; Paterson BM; Wang Y; Young JD; Hider RC; Blower PJ
Dalton Trans; 2019 Mar; 48(13):4299-4313. PubMed ID: 30860215
[TBL] [Abstract][Full Text] [Related]
18. Imaging Characteristics and First Experience of [
Derlin T; Schmuck S; Juhl C; Teichert S; Zörgiebel J; Wester HJ; Schneefeld SM; Walte ACA; Thackeray JT; Ross TL; Bengel FM
Mol Imaging Biol; 2018 Aug; 20(4):650-658. PubMed ID: 29344901
[TBL] [Abstract][Full Text] [Related]
19. In Vitro and In Vivo Characterization of an
Lütje S; Franssen GM; Herrmann K; Boerman OC; Rijpkema M; Gotthardt M; Heskamp S
J Nucl Med; 2019 Jul; 60(7):1017-1022. PubMed ID: 30655329
[TBL] [Abstract][Full Text] [Related]
20. Influence of a novel, versatile bifunctional chelator on theranostic properties of a minigastrin analogue.
Pfister J; Summer D; Rangger C; Petrik M; von Guggenberg E; Minazzi P; Giovenzana GB; Aloj L; Decristoforo C
EJNMMI Res; 2015 Dec; 5(1):74. PubMed ID: 26669693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
